Rating Change
William Blair analysts initiated coverage on Tango Therapeutics, Inc. (NASDAQ:TNGX) with a rating of Outperform on October 16, 2026.
new coverageNASDAQ:TNGX
William Blair Initiates Coverage on Tango Therapeutics, Inc. (TNGX) with Outperform
William Blair analysts initiated coverage on Tango Therapeutics, Inc. (NASDAQ:TNGX) with a rating of Outperform on October 16, 2026.
At publication ·
What changed
Tango Therapeutics, Inc. (NASDAQ:TNGX) · new coverage
- Firm
- William Blair
- Rating
- Outperform
- Price at event
- $22.16
- Market capitalization
- $1.0B
At a glance
Key takeaways
- William Blair initiated coverage of Tango Therapeutics with an Outperform rating on October 16, 2026.
- TNGX stock trades at $22.16 with a $1.0B market capitalization and gained 160.9% over the past 52 weeks.
Market Context
Tango Therapeutics, Inc. operates in the Healthcare sector. The stock currently trades at $22.16 with a market capitalization of $1.0B. The stock has gained 160.9% over the past 52 weeks.
Analyst coverage from William Blair provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Tango Therapeutics, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Tango Therapeutics, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 16, 2026 | William Blair | Outperform | N/A |
| Aug 18, 2026 | HC Wainwright & Co. | Buy | N/A |
| Aug 12, 2026 | Guggenheim | Buy | N/A |
| Jul 17, 2026 | Mizuho | Outperform | N/A |
| Jul 15, 2026 | JP Morgan | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View TNGX Stock Page
Frequently Asked Questions
What does the Outperform rating mean for TNGX?
A rating of Outperform from William Blair reflects the analyst's outlook on Tango Therapeutics, Inc. (NASDAQ:TNGX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the TNGX forecast page.